MFDS — authorised 20 February 1945
- Marketing authorisation holder: BRISTOL MYERS SQUIBB
- Status: likely_approved
🇰🇷 Dextrotubocurarine Chloride in South Korea
MFDS authorised Dextrotubocurarine Chloride on 20 February 1945
Marketing authorisation
Dextrotubocurarine Chloride in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Dextrotubocurarine Chloride approved in South Korea?
Yes. MFDS authorised it on 20 February 1945.
Who is the marketing authorisation holder for Dextrotubocurarine Chloride in South Korea?
BRISTOL MYERS SQUIBB holds the South Korean marketing authorisation.